MGC Pharmaceuticals (ASX:MXC) Share Price and News - StockTrack

Market Cap (29-Apr) $18,417,672 (949th)	Close (30-Jun) $0.005 0 (0%)	Volume (30-Jun) 14,697,042	Shortsold (2-Apr) 218 (0.00%) (630th)
52w High $9.00	52w Low $0.300	P/E 14.90	EPS -3.21

	Subject
	MXC MXC Ann: Notification regarding unquoted securities - MXC
	1 (current) 2 3
	MXC MXC Ann: Provision of US$600,000 Funding and change of CFO
	MXC MXC Ann: s708A(12C)(e) Cleansing Notice
	MXC MXC Ann: Proposed issue of securities - MXC
	MXC MXC Ann: Proposed issue of securities - MXC
	MXC MXC Ann: Refinancing and Extension to Convertible Security Agreements
	MXC MXC Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	MXC MXC Ann: Change of External Financial Auditor
	MXC MXC Ann: Results of CimetrA bioanalytics pre-clinal trial
	MXC MXC Ann: Final Director's Interest Notice
	MXC MXC Ann: Internal Costs Review Completed and Board Change
	MXC MXC Ann: Notification regarding unquoted securities - MXC
	MXC MXC Ann: Proposed issue of securities - MXC
	MXC MXC Ann: s708A(12)(e) Cleansing Notice
	MXC MXC Ann: $800,000 of funding received through Mercer Facility
	MXC MXC Ann: Completion of CimetrA Efficacy Pre-clinical Trial
	MXC MXC Ann: US$1,000,000 ArtemiC order delivered to US partner, AMC
	MXC MXC Ann: Publication of Peer Reviewed Glioblastoma Research
	MXC MXC Ann: Results of Meeting
	MXC MXC Ann: Investor Presentation
	MXC MXC Ann: AGM Webcast Registration Instructions
	MXC MXC Ann: s708A(5)(e) Cleansing Notice
	MXC MXC Ann: Application for quotation of securities - MXC
	MXC MXC Ann: Application for quotation of securities - MXC
	MXC MXC Ann: Notification regarding unquoted securities - MXC
	MXC MXC Ann: s708A(12C)(e) Cleansing Notice
	MXC MXC Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	MXC MXC Ann: Proposed issue of securities - MXC
	MXC MXC Ann: Dispatch of 2022 Annual General Meeting documents
	MXC MXC Ann: Long COVID study Results
	MXC MXC Ann: Trading Halt
	MXC MXC Ann: Pause in Trading
	MXC MXC Ann: Operations Update
	MXC MXC Ann: Annual Report to shareholders
	MXC MXC Ann: Notice of Annual General Meeting/Proxy Form
	MXC MXC Ann: Results of Meeting
	MXC MXC Ann: Appointment of UK Corporate Advisor and Company Update
	MXC MXC Ann: Appendix 4G Corporate Governance Key Disclosures
	MXC MXC Ann: Full Year Statutory Accounts
	MXC MXC Ann: TGA advertising Infringement Notice
	MXC MXC Ann: Notification regarding unquoted securities - MXC
	MXC MXC Ann: US$550,000 Convertible Note Facility Funding
	MXC MXC Ann: s708A(12C)(e) Cleansing Notice
	MXC MXC Ann: Proposed issue of securities - MXC
	MXC MXC Ann: Interim Results - CimetrA Dosing Finding Study
	MXC MXC Ann: Website and Social Media Update
	MXC MXC Ann: Letter to Shareholders-Dispatch of General Meeting Documents
	MXC MXC Ann: Notice of General Meeting/Proxy Form
	MXC MXC Ann: Preliminary Final Report
	MXC MXC Ann: s708A(5)(e) Cleansing Notice

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
29-Apr	$0.42	6,035	0.00 (0.00%)
26-Apr	$0.42	1,033	+0.01 (2.47%)
24-Apr	$0.41	6,603	-0.03 (5.81%)
23-Apr	$0.43	0	0.00 (0.00%)
22-Apr	$0.43	5,109	0.00 (0.00%)
19-Apr	$0.43	4,257	0.00 (0.00%)
18-Apr	$0.43	0	0.00 (0.00%)
17-Apr	$0.43	2	-0.01 (1.15%)
16-Apr	$0.44	18,828	-0.01 (2.25%)
15-Apr	$0.45	11,403	0.00 (0.00%)
12-Apr	$0.45	49,208	+0.01 (2.30%)
11-Apr	$0.44	8,542	+0.02 (4.82%)
10-Apr	$0.42	6,145	-0.02 (3.49%)
09-Apr	$0.43	43,411	+0.02 (3.61%)
08-Apr	$0.42	27,077	+0.01 (1.22%)
5 up, 4 down, and 6 flat days

High $0.01	Low $0.00	Trades 68	Turnover $72,477	Volume 14,697,042
30 June 2023 at 4:10pm

High $0.01	Low $0.00	Trades 68	Turnover $72,477	Volume 14,697,042
30 June 2023 at 4:10pm

MGC Pharmaceuticals Health Care

$0.005 (0%)

$0.005 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices